Clinical Trial Update: International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized, placebo-controlled trial evaluating the efficacy and safety of BCD-085 in ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• BCD-085

Snippet

Sponsor: Biocad | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED